Short term health-related quality of life improvement during opioid agonist treatment

Highlights • We examine short-term health utility of patients on opioid agonist treatment (OAT). • OAT initially improves health utility across all treatment modalities and patients. • Health utility subsequently decreases slightly or increases at diminished rate. • Results suggest a threshold level...

Full description

Saved in:
Bibliographic Details
Published in:Drug and alcohol dependence 2015-12, Vol.157, p.121-128
Main Authors: Nosyk, B, Bray, J.W, Wittenberg, E, Aden, B, Eggman, A.A, Weiss, R.D, Potter, J, Ang, A, Hser, Y.-I, Ling, W, Schackman, B.R
Format: Article
Language:English
Subjects:
Adult
Analgesics, Opioid - adverse effects
Analgesics, Opioid - therapeutic use
Buprenorphine, Naloxone Drug Combination - therapeutic use
Buprenorphine/naloxone
Cost-Benefit Analysis
Female
Health related quality of life
Health Status
Health utility
Heroin - adverse effects
HRQoL
Humans
Male
Methadone
Methadone - therapeutic use
Middle Aged
Opiate Substitution Treatment - methods
Opiate Substitution Treatment - psychology
Opioid agonist treatment
Opioid use disorder
Opioid-Related Disorders - drug therapy
Opioid-Related Disorders - psychology
Psychiatry
Quality of Life - psychology
Randomized Controlled Trials as Topic
Suboxone
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Highlights • We examine short-term health utility of patients on opioid agonist treatment (OAT). • OAT initially improves health utility across all treatment modalities and patients. • Health utility subsequently decreases slightly or increases at diminished rate. • Results suggest a threshold level in health-related quality of life response to OAT.
ISSN:0376-8716
1879-0046
DOI:10.1016/j.drugalcdep.2015.10.009